Fenchone attenuates CD68-dependent 7-ketocholesterol accumulation, cholesterol dyshomeostasis and inflammatory responses via modulation of macrophage polarization
- PMID: 40591211
- DOI: 10.1007/s10787-025-01836-5
Fenchone attenuates CD68-dependent 7-ketocholesterol accumulation, cholesterol dyshomeostasis and inflammatory responses via modulation of macrophage polarization
Abstract
Background: Foam cell formation, driven by oxidized low-density lipoprotein (Ox-LDL) uptake, particularly 7-ketocholesterol (7KCh), is a pivotal event in lipid-associated inflammatory diseases such as atherosclerosis. Conventional therapies often yield side effects, prompting interest in plant-derived biomolecules. Fenchone, a monoterpene from Foeniculum vulgare, has recently garnered attention for its anti-inflammatory and anti-lipidemic potential.
Purpose: This study elucidates the pharmacologic efficacy of fenchone in mitigating foam cell formation by modulating cholesterol homeostasis, inflammatory signaling and polarization in macrophages.
Methods: Murine IC-21 macrophages were induced with 7KCh and co-treated with fenchone. Cell viability was assessed using alamar blue assay, while lipid and calcium accumulation were analyzed with oil red O and alizarin red S staining. Pinocytosis, phagocytosis and actin cytoskeleton were evaluated with neutral red, goat RBCs uptake and phalloidin, respectively. Molecular changes were determined using ELISA, flow cytometry, PCR, western blot and in silico docking.
Results: Fenchone significantly inhibited lipid and calcium accumulation, reduced lipid peroxidation and restored homeostatic endocytosis with anti-inflammatory cytoskeleton. It enhanced anti-inflammatory TGFβ1 and Smad2/3 while suppressing pro-inflammatory NF-κB, IL-1β, IL-6 and TNF-α. In addition, fenchone regulated cholesterol homeostasis via ABCA1, ApoE, LXR, CD36 and promoted M2 polarization by increasing CD163 and CD206 markers, downregulating M1 markers (CD38, CD68 and CD86). Computational analysis indicated the interactive affinity of 7KCh toward the CD68 scavenger receptor, which was prevented by fenchone.
Conclusion: These findings highlight the therapeutic potential of fenchone in managing atherosclerosis by targeting CD68-mediated 7KCh uptake and inflammatory cascade, thereby emerging as a potential pharmacotherapeutic agent in inflammatory diseases.
Keywords: 7-ketocholesterol; Fenchone; Inflammation; Lipids; Macrophage.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest statement: The authors declare no conflict of interest.
Similar articles
-
Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy.PLoS One. 2025 Jun 27;20(6):e0326687. doi: 10.1371/journal.pone.0326687. eCollection 2025. PLoS One. 2025. PMID: 40577270 Free PMC article.
-
Hydroxysafflor yellow A attenuates the inflammatory response in cerebral ischemia-reperfusion injured mice by regulating microglia polarization per SIRT1-mediated HMGB1/NF-κB signaling pathway.Int Immunopharmacol. 2025 Feb 6;147:114040. doi: 10.1016/j.intimp.2025.114040. Epub 2025 Jan 10. Int Immunopharmacol. 2025. PMID: 39798476
-
Lupeol Attenuates Oxysterol-Induced Dendritic Cell Activation Through NRF2-Mediated Antioxidant and Anti-Inflammatory Effects.Int J Mol Sci. 2025 Jul 25;26(15):7179. doi: 10.3390/ijms26157179. Int J Mol Sci. 2025. PMID: 40806311 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- Ahmad W, Ansari MA, Yusuf M, Amir M, Wahab S, Alam P, Alomary MN, Alhuwayri AA, Khan M, Ali A, Warsi MH (2022) Antibacterial, anticandidal, and antibiofilm potential of fenchone: in vitro, molecular docking and in silico/ADMET study. Plants 11(18):2395. https://doi.org/10.3390/plants11182395 - DOI - PubMed - PMC
-
- Anderson A, Campo A, Fulton E, Corwin A, Jerome WG III, O’Connor MS (2020) 7-Ketocholesterol in disease and aging. Redox Biol 29:101380. https://doi.org/10.1016/j.redox.2019.101380 - DOI - PubMed
-
- Araruna ME, Júnior EB, Serafim CA, Pessoa MM, Pessôa ML, Alves VP, Silva MS, Sobral MV, Alves AF, Nunes MK, Araújo AA (2024) (-)-Fenchone Prevents cysteamine-induced duodenal ulcers and accelerates healing promoting re-epithelialization of gastric ulcers in rats via antioxidant and immunomodulatory mechanisms. Pharmaceuticals 17(5):641. https://doi.org/10.3390/ph17050641 - DOI - PubMed - PMC
-
- Azadpour M, Farajollahi MM, Dariushnejad H, Varzi AM, Varezardi A, Barati M (2021) Effects of synthetic silymarin-PLGA nanoparticles on M2 polarization and inflammatory cytokines in LPS-treated murine peritoneal macrophages. Iran J Basic Med Sci 24(10):1446. https://doi.org/10.22038/IJBMS.2021.59312.13161
-
- Bai J, Zhang X, Meng W, Xu H, Liu Y, Zhong Y, Lin X, Wang J, Lv G, Gu Y (2024) Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-κB in glioma. Phytomedicine 128:155417. https://doi.org/10.1016/j.phymed.2024.155417 - DOI - PubMed
LinkOut - more resources
Research Materials
Miscellaneous